Patents by Inventor Walter R. Laredo

Walter R. Laredo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230372236
    Abstract: Polymeric eye inserts are provided that may be dissolvable when placed in the cul-de-sac of the eye. These inserts may contain one or more polymers as well as a softener/plasticizer so that, when inserted into the eye, they may absorb tears, and dissolve and slowly release lubricant into the tear film to lubricate and protect the ocular surface for an extended duration of time. Increased retention time on the ocular surface for longer lasting relief may reduce dosing frequency and patient burden typically associated with topical drop usage. These polymeric eye inserts also may include one or more pharmaceutically active agents.
    Type: Application
    Filed: October 5, 2021
    Publication date: November 23, 2023
    Inventors: Stephen John COLLINS, Howard Allen KETELSON, Walter R. LAREDO
  • Publication number: 20200345544
    Abstract: Polymeric eye inserts are provided that may be dissolvable when placed in the cul-de-sac of the eye. These inserts may contain one or more polymers as well as a softener/plasticizer so that, when inserted into the eye, they may absorb tears, and dissolve and slowly release lubricant into the tear film to lubricate and protect the ocular surface for an extended duration of time. Increased retention time on the ocular surface for longer lasting relief may reduce dosing frequency and patient burden typically associated with topical drop usage. These polymeric eye inserts also may include one or more pharmaceutically active agents.
    Type: Application
    Filed: May 1, 2020
    Publication date: November 5, 2020
    Inventors: Howard Allen Ketelson, Rekha Rangarajan, Walter R. Laredo, Stephen John Collins
  • Patent number: 10472319
    Abstract: Described herein are dimethyl acetal-containing UV-absorbing compounds and their uses in preparing UV-absorbing polyvinyl alcohol prepolymers suitable for producing UV-absorbing contact lenses capable of blocking ultra-violet (“UV”) radiation and optionally (but preferably) violet radiation with wavelengths from 380 nm to 440 nm, thereby protecting eyes to some extent from damages caused by UV radiation and potentially from violet radiation. This invention also provides a UV-absorbing polyvinyl alcohol prepolymer.
    Type: Grant
    Filed: May 2, 2019
    Date of Patent: November 12, 2019
    Assignee: Novartis AG
    Inventors: Frank Chang, Ryan DeSousa, Troy Vernon Holland, Walter R. Laredo
  • Publication number: 20190256455
    Abstract: Described herein are dimethyl acetal-containing UV-absorbing compounds and their uses in preparing UV-absorbing polyvinyl alcohol prepolymers suitable for producing UV-absorbing contact lenses capable of blocking ultra-violet (“UV”) radiation and optionally (but preferably) violet radiation with wavelengths from 380 nm to 440 nm, thereby protecting eyes to some extent from damages caused by UV radiation and potentially from violet radiation. This invention also provides a UV-absorbing polyvinyl alcohol prepolymer.
    Type: Application
    Filed: May 2, 2019
    Publication date: August 22, 2019
    Inventors: Frank Chang, Ryan DeSousa, Troy Vernon Holland, Walter R. Laredo
  • Patent number: 10322993
    Abstract: Described herein are dimethyl acetal-containing UV-absorbing compounds and their uses in preparing UV-absorbing polyvinyl alcohol prepolymers suitable for producing UV-absorbing contact lenses capable of blocking ultra-violet (“UV”) radiation and optionally (but preferably) violet radiation with wavelengths from 380 nm to 440 nm, thereby protecting eyes to some extent from damages caused by UV radiation and potentially from violet radiation. This invention also provides a UV-absorbing polyvinyl alcohol prepolymer.
    Type: Grant
    Filed: November 15, 2016
    Date of Patent: June 18, 2019
    Assignee: Novartis AG
    Inventors: Frank Chang, Ryan DeSousa, Troy Vernon Holland, Walter R. Laredo
  • Patent number: 10268053
    Abstract: Described herein are UV-absorbing vinylic monomers and their uses in preparing UV-absorbing contact lenses capable of blocking ultra-violet (“UV”) radiation and violet radiation with wavelengths from 380 nm to 440 nm, thereby protecting eyes to some extent from damages caused by UV radiation and potentially from violet radiation.
    Type: Grant
    Filed: February 16, 2017
    Date of Patent: April 23, 2019
    Assignee: Novartis AG
    Inventors: Troy Vernon Holland, Frank Chang, Walter R. Laredo, Xuwei Jiang, Ryan DeSousa
  • Publication number: 20170242274
    Abstract: Described herein are UV-absorbing vinylic monomers and their uses in preparing UV-absorbing contact lenses capable of blocking ultra-violet (“UV”) radiation and violet radiation with wavelengths from 380 nm to 440 nm, thereby protecting eyes to some extent from damages caused by UV radiation and potentially from violet radiation.
    Type: Application
    Filed: February 16, 2017
    Publication date: August 24, 2017
    Inventors: Troy Vernon Holland, Frank Chang, Walter R. Laredo, Xuwei Jiang, Ryan DeSousa
  • Publication number: 20170158611
    Abstract: Described herein are dimethyl acetal-containing UV-absorbing compounds and their uses in preparing UV-absorbing polyvinyl alcohol prepolymers suitable for producing UV-absorbing contact lenses capable of blocking ultra-violet (“UV”) radiation and optionally (but preferably) violet radiation with wavelengths from 380 nm to 440 nm, thereby protecting eyes to some extent from damages caused by UV radiation and potentially from violet radiation. This invention also provides a UV-absorbing polyvinyl alcohol prepolymer.
    Type: Application
    Filed: November 15, 2016
    Publication date: June 8, 2017
    Inventors: Frank Chang, Ryan DeSousa, Troy Vernon Holland, Walter R. Laredo
  • Patent number: 9372282
    Abstract: Disclosed are improved ophthalmic and otorhinolaryngological device materials and devices formed therewith. The device materials are soft, high refractive index styrenic device materials that are used to form the ophthalmic or otorhinolaryngological devices, particularly ophthalmic implants (e.g., intraocular lenses).
    Type: Grant
    Filed: August 28, 2012
    Date of Patent: June 21, 2016
    Assignee: Novartis AG
    Inventors: Xuwei Jiang, Walter R. Laredo
  • Patent number: 9012581
    Abstract: Disclosed are soft, high refractive index, acrylic device materials. The materials contain a copolymeric additive for glistening resistance.
    Type: Grant
    Filed: August 23, 2010
    Date of Patent: April 21, 2015
    Assignee: Novartis AG
    Inventor: Walter R. Laredo
  • Patent number: 8969429
    Abstract: Disclosed are low-tack, hydrophobic, high refractive index, acrylic materials. These materials, especially useful as intraocular lens materials, contain one or more aryl acrylic hydrophobic monomers as principal device-forming monomers, a tack-reducing block copolymer additive and a glistening-reducing additive. In addition to their use as intraocular lens materials, the present materials are also suitable for use in other implantable ophthalmic devices.
    Type: Grant
    Filed: February 7, 2012
    Date of Patent: March 3, 2015
    Assignee: Novartis AG
    Inventors: Walter R. Laredo, Xuwei Jiang
  • Publication number: 20140024777
    Abstract: Disclosed are soft, high refractive index, acrylic device materials. The materials contain a functionalized alkylphenol ethoxylate to reduce glistenings.
    Type: Application
    Filed: September 24, 2013
    Publication date: January 23, 2014
    Inventors: Walter R. Laredo, Douglas C. Schlueter
  • Patent number: 8585938
    Abstract: UV absorbing compounds that are effective in blocking UV and short-wavelength blue light are disclosed. The UV absorbing compounds are particularly suitable for use in intraocular lens materials.
    Type: Grant
    Filed: March 29, 2013
    Date of Patent: November 19, 2013
    Assignee: Novartis AG
    Inventors: David L. Jinkerson, Walter R. Laredo
  • Patent number: 8557892
    Abstract: Disclosed are low-tack, hydrophobic, high refractive index, acrylic materials. These materials, especially useful as intraocular lens materials, contain one or more aryl acrylic hydrophobic monomers as principal device-forming monomers, a tack-reducing macromer additive and a glistening-reducing additive. In addition to their use as intraocular lens materials, the present materials are also suitable for use in other implantable ophthalmic devices.
    Type: Grant
    Filed: June 1, 2012
    Date of Patent: October 15, 2013
    Assignee: Novartis AG
    Inventor: Walter R. Laredo
  • Patent number: 8475691
    Abstract: Novel UV absorbing monomers are disclosed. The UV absorbers are particularly suitable for use in intraocular lens materials.
    Type: Grant
    Filed: August 14, 2012
    Date of Patent: July 2, 2013
    Assignee: Novartis AG
    Inventor: Walter R. Laredo
  • Patent number: 8466209
    Abstract: Disclosed are low-tack, hydrophobic, high refractive index, acrylic materials. These materials, especially useful as intraocular lens materials, contain one or more aryl acrylic hydrophobic monomers as principal device-forming monomers, a tack-reducing macromer additive and a glistening-reducing additive. In addition to their use as intraocular lens materials, the present materials are also suitable for use in other implantable ophthalmic devices.
    Type: Grant
    Filed: May 31, 2012
    Date of Patent: June 18, 2013
    Assignee: Novartis AG
    Inventors: Ali E. Akinay, Walter R. Laredo
  • Patent number: 8449610
    Abstract: High refractive index copolymers with reduced glistenings are disclosed. The copolymers, which are particularly suitable for use as ophthalmic device materials, comprise a high molecular weight, reactive, linear polyethylene glycol component.
    Type: Grant
    Filed: June 20, 2011
    Date of Patent: May 28, 2013
    Assignee: Novartis AG
    Inventors: Walter R. Laredo, Charles Freeman, Thomas A. Callaghan
  • Publication number: 20130043443
    Abstract: Novel UV absorbing monomers are disclosed. The UV absorbers are particularly suitable for use in intraocular lens materials.
    Type: Application
    Filed: August 14, 2012
    Publication date: February 21, 2013
    Applicant: Novartis AG
    Inventor: Walter R. Laredo
  • Publication number: 20130030079
    Abstract: High refractive index copolymers with reduced tack are disclosed. The copolymers, which are particularly suitable for use as ophthalmic device materials, comprise a benzhydryl methacrylate or benzydryl methacrylate derivative monomer.
    Type: Application
    Filed: May 4, 2011
    Publication date: January 31, 2013
    Applicant: NOVARTIS AG
    Inventors: Chance Lehman, Charles Freeman, Walter R. Laredo, Ali E. Akinay, Joseph I. Weinschenk, III
  • Patent number: 8362177
    Abstract: High refractive index copolymers with reduced tack are disclosed. The copolymers, which are particularly suitable for use as ophthalmic device materials, comprise a benzhydryl methacrylate or benzhydryl methacrylate derivative monomer.
    Type: Grant
    Filed: May 4, 2011
    Date of Patent: January 29, 2013
    Assignee: Novartis AG
    Inventors: Chance Lehman, Charles Freeman, Walter R. Laredo, Ali E. Akinay, Joseph I. Weinschenk, III